摘要
目的观察孟鲁司特治疗中度哮喘的临床效果。方法根据纳入和排除标准筛选30例中度哮喘患者参加了本试验,接受孟鲁司特治疗4周后判断其临床疗效。结果治疗前后日夜间无症状天数百分数、哮喘症状评分、最大呼气流量和喘乐宁气雾剂喷数有显著的统计学意义的改善(各项指标P<0.01)。结论孟鲁司特治疗中度哮喘有效。
Objective:To observe the clinic efficacy of montelukast on midrange asthma.Methods: According to the inclusion and exclusion criteria 30 midrange asthma patients involved in this trial treat and received the treatment of montelukast for 4 weeks.The clinic efficacy of montelukast was judged.Results: There was statistically significant amelioration between pre-treatment and post-treatment with regard to the percentage of the number of the symptomless day,the score of the asthma symptom,the peak expiratory flow(PEF),and the puff number of the salbutamol of the day and the night(P<0.01).Conclusion: Montelukast can effectively treat midrange asthma.operative.
出处
《井冈山大学学报（自然科学版）》
2006年第6期93-95,共3页
Journal of Jinggangshan University (Natural Science)
